Pharmacogenetic-based dosing of warfarin

Mark Abramowicz, Gianna Zuccotti, Jean Marie Pflomm, Susan Morey, Eric J. Epstein, Philip D. Hansten, Jules Hirsch, David N. Juurlink, Richard B. Kim, Gerald L. Mandell, Hans Meinertz, Dan M. Roden, F. Estelle R. Simons, Neal H. Steigbigel, Donna Goodstein, Amy Faucard, Cynthia Macapagal Covey, Vanessa K. Dalton, Lauren K. Schwartz, Liz DonohueCheryl Brown, Susie Wong, Gene Carbona, Cristine Romatowski, Joanne F. Valentino, Yosef Wissner-Levy

Research output: Contribution to journalShort survey

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)39-40
Number of pages2
JournalMedical Letter on Drugs and Therapeutics
Volume50
Issue number1286
StatePublished - May 19 2008

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Abramowicz, M., Zuccotti, G., Pflomm, J. M., Morey, S., Epstein, E. J., Hansten, P. D., Hirsch, J., Juurlink, D. N., Kim, R. B., Mandell, G. L., Meinertz, H., Roden, D. M., Simons, F. E. R., Steigbigel, N. H., Goodstein, D., Faucard, A., Covey, C. M., Dalton, V. K., Schwartz, L. K., ... Wissner-Levy, Y. (2008). Pharmacogenetic-based dosing of warfarin. Medical Letter on Drugs and Therapeutics, 50(1286), 39-40.